QT
ENTA icon

Quantamental Technologies’s Enanta Pharmaceuticals ENTA Stock Holding History

Quantamental Technologies’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,334
Closed -$205K – 547
2022
Q2 		$205K Buy
+4,334
New +$235K 0.09% 349
2022
Q1 		– Sell
-2,724
Closed -$204K – 426
2021
Q4 		$204K Buy
+2,724
New +$214K 0.1% 331
2019
Q4 		– Sell
-2,446
Closed -$147K – 691
2019
Q3 		$147K Buy
2,446
+1,852
+312% +$138K 0.05% 597
2019
Q2 		$50K Sell
594
-2,921
-83% -$263K 0.02% 894
2019
Q1 		$336K Buy
+3,515
New +$315K 0.15% 210

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Quantamental Technologies's ENTA Position: Q3 2022 in Review

Quantamental Technologies sold out of Enanta Pharmaceuticals (ENTA) in Q3 2022, closing a stake of 4,334 shares — an estimated $205K sold.

Quantamental Technologies first reported a position in ENTA in Q1 2019 and held it in 5 quarters. The position peaked at $336K in Q1 2019. 159 funds tracked by Wall St. Rank hold ENTA as of Q3 2022.

  • Quantamental Technologies reported no remaining Enanta Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 4,334 Enanta Pharmaceuticals shares in Q3 2022, an estimated $205K.
  • Quantamental Technologies first reported a position in Enanta Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • Quantamental Technologies's Enanta Pharmaceuticals position peaked at $336K in Q1 2019.
  • 159 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.